Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $208M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Akebia Therapeutics USD 502M 75M Mar/2025
ALKERMES USD 4.62B 333M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 341M 4M Sep/2025
Amgen USD 176.25B 24.32B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 94M 65M Mar/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Fujifilm JPY 4.03T 548.71B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025